Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2026-04-16 @ 4:00 PM
Study NCT ID:
NCT01183312
Status:
COMPLETED
Last Update Posted:
2017-12-12
First Post:
2010-08-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Flumazenil for the Treatment of Primary Hypersomnia
Sponsor:
Lynn Marie Trotti
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IRB00044836
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |